Research ID
hum0251-v1Release info
Research title
Phase II clinical trial of adult Philadelphia chromosome-negative precursor B-cell acute lymphocytic leukemia with combination chemotherapy
Research overview
- Aims
- Elucidation of molecular pathology for B-cell acute lymphocytic leukemia (B-ALL) by genomic analysis
- Methods
- RNA Sequencing and target capture sequencing analyses
- Participants/materials
- Philadelphia chromosome-negative (Ph-negative) B-ALL
- URL
- N/A
Datasets
| Cart | Dataset ID | Type of data | Analysis method | Access criteria | Date published |
|---|---|---|---|---|---|
| JGAD000384 | NGS (RNA-seq, Target Capture) |
| Controlled-access (Type I) | 2022-11-29 |
Data provider
- Principal investigator
- Yoshihiro Hatta
- Affiliation
- Division of Hematology and Rheumatology, Nihon University School of Medicine
Research projects
| Name | URL |
|---|---|
JALSG Ph(-)B-ALL213 | N/A |
Grants
| Name | Title | Project number |
|---|---|---|
Practical Research for Innovative Cancer Control, Japan Agency for Medical Research and Development (AMED) | Treatment with a pediatric protocols and stritified strateiesy by gene panel testing for adolescents and young adults with acute lymphoblastic leukemia |
|
Related publications
| Title | DOI | Dataset ID |
|---|---|---|
Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations |
Controlled access users
| Principal investigator | Affiliation | Country/Region | Research title | Period of data use | Dataset ID |
|---|---|---|---|---|---|
| Michiaki Hamada | Hamada Laboratory, Faculty of Science and Engineering, Waseda University | Japan | Construction of RNA-targeted Drug Discovery Database | 2023-01-05 – 2027-10-31 |